Navigation Links
Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
Date:11/9/2007

KIRKLAND, Wash., Nov. 9 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) announced today that is has received notice of the issuance of a U.S. patent (U.S. Patent No. 7,282,222) for its unique methods and compositions approach to deliver and direct stem cells to target organs in the body.

Using this now-patented technology, exclusively licensed to CellCyte from the US Department of Veterans Affairs, the company is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased and other target organs, such as the heart.

Dr. Ronald Berninger, Chief Scientific Officer of CellCyte Genetics explains, "The goal of CellCyte's stem cell targeting/retention therapies is to enhance the number of cells available for regeneration of damaged tissue, and thereby markedly increase opportunities for healing and restoring organ function. The company's first product in development, CCG-TH30, is designed to target autologous bone-marrow-derived (adult) stem cells to the heart of patients after a heart attack."

"In preclinical models, CCG-TH30 has been shown to increase the retention of stem cells up to as much as 77% in pre-clinical models as compared to conventional methods, which achieve only up to about 6%," Berninger states. "Importantly, CellCyte's product candidate, along with stem cells, can both be delivered intravenously through a patient's circulatory system without an invasive procedure."

Company CEO, President and Chairman, Gary A. Reys emphasizes the importance of the patent's issuance to the company's position. Reys states, "This patented technology is significant, as it has the potential to fill an important missing piece in the field of regenerative medicine, namely, the ability to target and then keep cells in an organ of interest, in this case, the heart. The issuance of a patent for this platform assures
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)..., July 3 /- On June 27, 2008,GeneraMe...Drug,Administration (FDA) for its Epoprostenol for...oprostenol for Injection 1.5 mg is indicated for t...onary hypertension and pulmonary,hypertension asso... NYHA,Class III and Class IV patients who do not r...
(Date:7/3/2008)...ewswire-FirstCall/ -- Advanced Life Sciences,Holdi...mpany engaged in the,discovery, development and co...areas of infection, cancer and respiratory disease...l Microcap(R) Index after the,Russell Investment G...nd,global equity indexes on June 27, 2008., (Logo...
(Date:7/3/2008)... July 3 /- Senesco,Technolo...T ) announced today,that it has contracted with Po...olyplus,s "in vivo-jetPEI" for systemic delivery o...actor 5A and a plasmid of the Factor,5A gene., Se... in vivo results,using its combination siRNA and p...
(Date:7/3/2008)... /Xinhua-- Huifeng,Bio-Phar...FGB), a leading,developer and producer of plant ex... pharmaceutical, nutraceutical and food production...ation will be made available via,Standard & Poor,s...n,service that enables subscribing publicly traded...
Breaking Biology Technology:GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2
...uite Scheduler, a provider of employee scheduling ...ance with ICE Technologies to resell Suite Schedul... , based in Iowa, focuses on delivering informatio...n the healthcare industry. The company will provid...at will include hardware, installation, training, ...
...work crash last week left many University of Wisc...ng just what exactly was wrong with their e-mail. ...nitors and sustains the UWs networks, experienced ...s of people without e-mail or Internet access. , ...he problem started after new code was installed la...
...te that may sound familiar if youve listened to Go...to create the very best business climate possible ... the good-paying jobs they provide. , ,That spea...of North Dakota. And might just as easily been Gov...tano of Arizona, or any of about 15 other governor...
... last weeks H&Q conference in San Francisco is sti...mpant, no breaking news made the Wall Street Journ...to be one of optimism. , ,Remember that there are...e Eyetech IPO (expected to be in the $150 million ... will be closely monitored. The last time the IPO ...
Other Biology Technology:Router Failure and Software Crash UW-Madison Network 2Wisconsin Cannot Dawdle if it Wants a Healthy State of the State 2Wisconsin Cannot Dawdle if it Wants a Healthy State of the State 32003 Biotech Results 2
(Date:7/3/2008)...dicine at UCLA have solved the structure of a clas...ers (SGLTs), which pump glucose into cells. These ...ronic diarrhea via oral rehydration therapy, savin... solution of the SGLT structure will accelerate de...with diabetes and cancer. , Led by Jeff Abramso...
(Date:7/3/2008)...d the regeneration of the tropical forest in Vietn... tropical forest, but only slowly. Two procedures ...to free up space for trees and planting the desire...to calculate the appropriate measures. , People... services the forest supplies. However, the natura...
(Date:7/3/2008)...ed wild orangutan (Pongo spp.) populations are dec...viously estimated, according to new findings publi...st Dr. Serge Wich and other orangutan conservation...nservation . , , Conservation action essential ...ds of Sumatra and Borneo, must be region-specific ...
(Date:7/2/2008)...he FASEB Journal provide more evidence that if we... improve. According to MIT scientists, dietary nut...formula to eggs increase brain synapses and improv...ll, like those of experimental animals, respond to...ses and thus restoring cognitive abilities," said ...
Breaking Biology News(10 mins):UCLA researchers clarify function of glucose transport molecule 2Giving nature a helping hand 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Doctors and medical ethicist discuss whether doctors should participate in capital punishment 447 1Doctors and medical ethicist discuss whether doctors should participate in capital punishment 447 2Heart of Herschel to be presented to media 243 1Annual flu shot cuts need for doctors visits hospitalization among children 440 1Annual flu shot cuts need for doctors visits hospitalization among children 440 2Biotech Finishes on a High in August Burrill Report Says 435 1Biotech Finishes on a High in August Burrill Report Says 435 2Biotech Finishes on a High in August Burrill Report Says 435 3Biotech Finishes on a High in August Burrill Report Says 435 4Biotech Finishes on a High in August Burrill Report Says 435 5
...ion (FDA) announced the approval of Baraclude (ent...t of chronic hepatitis B in adults. Chronic hepati... B virus (HBV) that attacks the liver. The virus c...of the liver, liver cancer, liver failure, and dea...nd Prevention, approximately 1.25 million American...
...n it comes to cravings, and a new study conducted ...uggests the difference may lie in their brains, se... smokers who report a greater urge to smoke after ... activity after viewing smoking-related images, su...okers who noted fewer cravings showed stable brain...
...C and The Common Cold, published in 1970, was a be...ue of the vitamin for cold prevention and treatmen...viewing all of the best clinical research on this ...he vitamin may be unjustified. , Robert M Douglas ...nd Harri Hemilä of the University of Helsinki, Fin...
...gent, researchers at UCLA,s Jonsson Cancer Center ...icine found a way to move an important biomarker e... one location in a cell ?where it could not be acc... , The discovery, outlined in the cover article o...cular Cancer Therapeutics, could have important im...
Other Biology News:Brain Scan Study of Smokers Reveals Signature of Craving 2Brain Scan Study of Smokers Reveals Signature of Craving 3Does vitamin C help prevent or treat the common cold? Maybe not, after all. 2UCLA cancer researchers shake loose hidden biomarker 2